Back

Diagnostics development hub to complement biomed research launched

[Press Release by Diagnostics Development Hub]

The Diagnostics Development Hub (DxD) will leverage strategic public-public and public-private partnerships to accelerate market readiness of locally developed diagnostic products.

These include collaborations with the healthcare and academic medical community including SingHealth, National University Health System, National Healthcare Group, as well as academic research organisations like the Singapore Clinical Research Institute. Multinationals such as Johnson & Johnson Innovation and Thermo Fisher Scientific along with SMEs and start-ups such as AITbiotech, Gencurix, HistoIndex, iPtec, InvitroCue, and MiRXES are also among the early supporters of the DxD Hub. 

Click here to read the full release.

Back

Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept